JOURNAL ARTICLE
Cytarabine/cytarabine/daunorubicin/etoposide
Year: 2022 Journal: Reactions Weekly Vol: 1917 (1)Pages: 201-201 Publisher: Adis, Springer Healthcare
Keywords:
Cytarabine Daunorubicin Etoposide Medicine Pharmacology Leukemia Internal medicine Chemotherapy
Metrics
0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
1
Refs
0.14
Citation Normalized Percentile
Is in top 1%
Is in top 10%
Topics
Fungal Infections and Studies
Health Sciences → Medicine → Epidemiology
Chemotherapy-related skin toxicity
Health Sciences → Medicine → Dermatology
Cancer and Skin Lesions
Health Sciences → Medicine → Dermatology
Related Documents
JOURNAL ARTICLE
Cytarabine/daunorubicin/etoposide
Journal: Reactions Weekly Year: 2013 Vol: 1439 (1)Pages: 13-13
JOURNAL ARTICLE
Cytarabine/daunorubicin/etoposide
Journal: Reactions Weekly Year: 2015 Vol: 1574 (1)Pages: 88-88
JOURNAL ARTICLE
Cytarabine/daunorubicin/etoposide
Journal: Reactions Weekly Year: 2013 Vol: 1441 (1)Pages: 13-13
JOURNAL ARTICLE
Cytarabine/daunorubicin/etoposide
Journal: Reactions Weekly Year: 2018 Vol: 1709 (1)Pages: 72-72
JOURNAL ARTICLE
Cytarabine/daunorubicin/etoposide
Journal: Reactions Weekly Year: 2022 Vol: 1923 (1)Pages: 173-173